- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03717116
Early Prediction of Hypocalcemia After Thyroidectomy Using Postoperative Second Hour Parathormone
October 22, 2018 updated by: Selen Soylu, MD, Istanbul University
Hypocalcemia is the most frequent complication in thyroid surgeries.
Diagnosing this complication earlier will reduce longer hospital stay and will lead to an earlier intervention.
The purpose of the study is to evaluate postoperative second hour parathyroid hormone measurement as a predictor for early stage hypocalcemia.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Anticipated)
110
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: selen soylu
- Phone Number: +905375653811
- Email: selen_soylu@yahoo.com
Study Locations
-
-
-
Istanbul, Turkey, 34158
- Recruiting
- Istanbul University
-
Contact:
- selen soylu, MD
- Phone Number: 5375653811
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 80 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
N/A
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
all patients with multinodular goiter, Graves, fine needle aspiartion biopsy with Bethesda 3-4 undergoing total thyroidectomy
Description
Inclusion Criteria:
- patients with multinodular goiter, Graves, fine needle aspiartion biopsy with Bethesda 3-4 undergoing total thyroidectomy
Exclusion Criteria:
- pregnant women
- patients with thyroid cancer or previous neck dissection
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
control-normocalcemia group
|
From the patients, blood will be taken preoperatively and postoperatively.
Other Names:
|
hypocalcemia group
|
From the patients, blood will be taken preoperatively and postoperatively.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
postoperative parathormone level
Time Frame: postoperative 2. hour
|
postoperative 2. hour
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 1, 2017
Primary Completion (Anticipated)
October 31, 2018
Study Completion (Anticipated)
December 1, 2018
Study Registration Dates
First Submitted
October 22, 2018
First Submitted That Met QC Criteria
October 22, 2018
First Posted (Actual)
October 24, 2018
Study Record Updates
Last Update Posted (Actual)
October 24, 2018
Last Update Submitted That Met QC Criteria
October 22, 2018
Last Verified
October 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 83045809-604.01.02, A-01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypocalcemia, Postoperative Parathormone
-
Hospital Universitari de BellvitgeRecruitingIatrogenic HypocalcemiaSpain
-
Instituto PalaciosNexentia S.A.S.CompletedHypocalcemia; DietarySpain
-
Siriraj HospitalActive, not recruitingHypocalcemia in PregnancyThailand
-
G. Hatzikosta General HospitalUnknownHypocalcemia After Total ThyroidectomyGreece
-
King Saud UniversityCompletedHypocalcemia | Hypomagnesemia | Hypomagnesemia With Secondary HypocalcemiaSaudi Arabia
-
Radboud University Medical CenterCompletedHypomagnesemia, Intestinal, With Secondary Hypocalcemia | Drug Induced Hypomagnesemia
-
University Hospital "Sestre Milosrdnice"UnknownPostoperative Complications | Hypocalcemia | Thyroid | Hormone Disturbance | Parathyroid DysfunctionCroatia
-
University of Roma La SapienzaCompletedEvaluation of iMmune Function in Post-surgical and AuToimmune HYpoparathyroidism (EMPATHY) (EMPATHY)Hypoparathyroidism | Hypoparathyroidism Postprocedural | Hypoparathyroidism Due to Impaired Parathormone SecretionItaly
-
University Hospital "Sestre Milosrdnice"UnknownPostoperative Complications | Hypocalcemia | Thyroid | Hormone Disturbance | Parathyroid Dysfunction | Calcium DisorderCroatia
-
Pak Emirates Military HospitalRecruiting
Clinical Trials on parathormone level
-
Bezmialem Vakif UniversityCompletedMyocardial Infarction | High-Density Lipoid DeficiencyTurkey
-
University Hospital, ToulouseNot yet recruiting
-
Johns Hopkins Bloomberg School of Public HealthCompleted
-
Anagram Therapeutics, Inc.RecruitingExocrine Pancreatic InsufficiencyUnited States
-
GI Biome, Inc.RecruitingCancer | Colorectal Cancer | Rectal Cancer | Solid Tumor | Sigmoid Colon Cancer | Rectosigmoid Junction CancerKorea, Republic of
-
University of ChicagoRecruitingLymphoma | Hodgkin Lymphoma | Non-hodgkin LymphomaUnited States
-
GlaxoSmithKlineCureVacActive, not recruitingInfluenza, HumanBelgium, Spain, Canada
-
Ehab L AtallahRecruitingAcute Myeloid Leukemia | T Cell Lymphoblastic Lymphoma | T Cell Acute Lymphoblastic LeukemiaUnited States
-
Yuhan CorporationCompletedRheumatic ArthritisKorea, Republic of
-
Janssen Research & Development, LLCCompleted